NEW YORK, June 5 /PRNewswire-FirstCall/ -- The following is being issued by NASDAQ
What:
David S. Tierney, President and CEO of Valera Pharmaceuticals, Inc will preside over the opening bell to celebrate its initial public offering on the NASDAQ.
Where: NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio When: Tuesday June 6th, 2006 at 9:30 a.m. EDT Contacts: Stuart Z. Levine Director, Investor Relations (609) 235-3202 slevine@valerapharma.com NASDAQ MarketSite: Stephanie Lowenthal; 646.441.5220 Feed Information:
The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA-5 C-band/transponder 14. The downlink frequency is 3980 horizontal; audio: 6.2/6.8. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Stephanie Lowenthal at (646) 441-5220.
Photos:
To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.
About Valera Pharmaceuticals, Inc [VLRX]:
Valera Pharmaceuticals is a specialty pharmaceutical company engaged in the development, acquisition, and commercialization of products to treat urology and endocrinology diseases and disorders. Valera applies its Hydron technology to develop compact, flexible implants that can release therapeutics at a controlled rate for up to twelve months. VANTAS(R), a once-per-year implant currently marketed by Valera for the palliative treatment of advanced prostate cancer, employs this drug delivery technology.
NASDAQ
CONTACT: Stephanie Lowenthal of NASDAQ, +1-646-441-5220; or Stuart Z.Levine, Director, Investor Relations of Valera Pharmaceuticals, Inc,+1-609-235-3202, slevine@valerapharma.com
Web site: http://www.nasdaq.com/
